Melanoma, the most serious skin cancer, claims thousands of lives yearly, with men dying at a higher rate due to delayed detection and treatment. Jim Crooks was shocked by his diagnosis, having no ...

Cancer can sadly affect anyone and everyone, and the signs of cancer being present in the body can vary. Recently, Redditor u ...

Patients with stage IV ovarian cancer can derive long-term benefits from neoadjuvant pembrolizumab and chemotherapy if they achieve a major pathologic response, according to research published in ...

Fewer than half of eligible patients with advanced ovarian cancer receive first-line maintenance treatments, highlighting ...

Table of contents In A Nutshell Drug Shows Selective Activity Against Ovarian Cancer Why Single Drugs Fall Short Combination Therapy Shows Superior Results Exploiting Cancer’s Vulnerabilities ...

Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to a preclinical study led by Weill Cornell Medicine investigators. The ...

Chemotherapy seeks to destroy tumor cells and has been a standard treatment for cancer for decades. However, it doesn't always work. "Chemotherapy is good for some patients, but it's not effective ...

Little is known about what causes ovarian cancer, and there is no way to detect it early yet. About 75% of the time when someone is diagnosed with ovarian cancer, it has already progressed to ...

A recent study published in Genes & Diseases reveals a novel role of XPR1 in promoting ovarian cancer growth by regulating autophagy and MHC-I expression.

The incidence of neuroendocrine tumors is increasing, necessitating the need for more post-operative medical strategies. Available therapies and promising agents are discussed in this article.